AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$18.71
+2.35%Forward multiples
Based on analyst estimates
- P/E forward
- 18.83x
- P/E 2026E
- 18.17x
- P/E 2027E
- 15.68x
- P/E 2028E
- 12.67x
- P/S forward
- 1.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.61x
- PEG TTM
- 0.37x
- Price / book
- 180.93x
- Price / sales
- 1.92x
- Price / cash flow
- 29.76x
Enterprise value
- Enterprise value
- $8.7B
- EV / sales
- 2.80x
- EV / EBITDA
- 13.37x
- EV / EBIT
- 21.63x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026